Concepedia

Adam Zermansky

AZ

Statistics

Publications

5

Citations

435

H-Index

5

Active since

2001

Affiliations

Eli Lilly (United Kingdom)(Current)

Adam Zermansky is an author at Eli Lilly (United Kingdom) specializing in diagnosis, neurology, and rehabilitation.

Top concepts

Publications per year

2001–2020

5

Publications

5

Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial

Heinrich P. Mattle, Stefan Evers, David Hildick‐Smith et al. · European Heart Journal · 2016 · 210 citations · Full text

Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy

Claudia B. Catarino, Bettina von Livonius, Claudia Priglinger et al. · Journal of Neuro-Ophthalmology · 2020 · 112 citations · Full text

Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy

David G. Millar, P D Griffiths, Adam Zermansky et al. · Movement Disorders · 2005 · 69 citations

Towards Global and Long-Term Neurological Gene Therapy: Unexpected Transgene Dependent, High-Level, and Widespread Distribution of HSV-1 Thymidine Kinase throughout the CNS

Adam Zermansky, Federico Bolognani, Daniel Stone et al. · Molecular Therapy · 2001 · 32 citations · Full text

Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations

Claire Brittain, Andrew McCarthy, Michael C. Irizarry et al. · Parkinsonism & Related Disorders · 2018 · 12 citations

, , +9

1–5 of 5